Enteral Stents Market Report 2026

The enteral stents market size has grown strongly in recent years. It will grow from $1.55 billion in 2025 to $1.67 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to gastrointestinal cancer prevalence, bowel obstruction cases, adoption of endoscopic procedures, hospital GI infrastructure growth, palliative care demand.

The enteral stents market size is expected to see strong growth in the next few years. It will grow to $2.22 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to aging population growth, minimally invasive surgery adoption, biodegradable stent development, oncology treatment expansion, advanced GI care access. Major trends in the forecast period include rising demand for minimally invasive GI procedures, increased use of palliative cancer care devices, growth in self-expandable metal stents, expansion of gastrointestinal oncology treatments, focus on long-term luminal patency.

The rising prevalence of gastrointestinal disorders is expected to drive the growth of the enteral stents market in the coming years. Gastrointestinal disorders encompass a broad range of conditions affecting the GI tract, including the esophagus, stomach, intestines, and accessory organs, often causing pain and discomfort. Factors contributing to the increasing prevalence of these disorders include poor dietary habits, higher stress levels, sedentary lifestyles, increased antibiotic use, and greater exposure to environmental toxins. Enteral stents play a crucial role in managing gastrointestinal disorders by providing a minimally invasive solution to relieve obstructions, restore normal food and fluid flow, and improve overall digestive function, thereby enhancing patient comfort and quality of life. For example, in June 2023, Crohn’s and Colitis Canada, a Canada-based nonprofit organization, reported that approximately 322,600 Canadians - around 0.8% of the population - were living with inflammatory bowel disease (IBD) in 2023. This number is projected to rise to 470,000, or 1.1% of the population, by 2035. Consequently, the growing prevalence of gastrointestinal disorders is fueling the enteral stents market.

The increasing prevalence of cancer is also expected to propel growth in the enteral stents market. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells within the body. Factors driving the rising incidence of cancer include an aging population, lifestyle influences, improved diagnostic capabilities, genetic predisposition, and greater healthcare access and awareness. Enteral stents are used to alleviate gastrointestinal obstructions caused by cancer, improving symptoms such as dysphagia and supporting adequate nutrient intake. For instance, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected that by 2050, over 35 million new cancer cases would occur, representing a 77% increase from the estimated 20 million cases in 2022. As a result, the rising cancer prevalence is contributing to the growth of the enteral stents market.

In February 2023, Olympus Corporation, a Japan-based manufacturer of optics and reprography products, acquired Taewoong Medical Co., Ltd. for $370 million. Through this acquisition, Olympus aims to strengthen its gastrointestinal (GI) endotherapy portfolio by incorporating Taewoong’s innovative technologies and product offerings, including metallic stents used in various GI procedures. Taewoong Medical Co., Ltd., based in South Korea, specializes in the manufacture of enteral stents.

Major companies operating in the enteral stents market are Cardinal Health Inc., Medtronic Inc., Boston Scientific Corporation, Olympus Corporation, Lepu Medical Technology (Beijing) Co Ltd., Endo‑Therapeutics Inc., Cook Medical, Micro‑Tech (Nanjing) Co Ltd., Merit Medical Systems Inc., ConMed Corporation, Medi‑Globe GmbH, Taewoong Medical Inc., ELLA‑CS s.r.o., S&G Biotech Inc., Nanwei Medical Technology Co Ltd, M I Tech Co Ltd, ACE Medical Devices Pvt Ltd, Allium Ltd, ENDOCOR GmbH & Co KG, Sewoon Medical Co Ltd, Changzhou Health Microport Medical Device Co Ltd, Medorah Meditek Pvt Ltd, Advin Health Care, ENDO‑FLEX GmbH, CITEC, QualiMed, W L Gore & Associates Inc., Becton Dickinson and Company.

North America was the largest region in the enteral stents market in 2025. The regions covered in the enteral stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the enteral stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the enteral stents market by increasing costs of imported stent materials, delivery systems, and endoscopic accessories. Hospitals and specialty clinics in developed regions are most affected due to reliance on imported stent technologies. These tariffs raise procedural costs by increasing device and accessory pricing, affecting patient access to minimally invasive interventions. However, they encourage domestic manufacturing of gastrointestinal devices.

The enteral stents market research report is one of a series of new reports that provides enteral stents market statistics, including enteral stents industry global market size, regional shares, competitors with a enteral stents market share, detailed enteral stents market segments, market trends and opportunities, and any further data you may need to thrive in the enteral stents industry. This enteral stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Enteral stents are medical devices placed within the digestive tract to relieve obstructions or narrowing, often caused by tumors or other gastrointestinal conditions. These stents help maintain an open passage for food or waste, offering temporary or long-term relief for patients with disorders such as cancer or Crohn’s disease.

The primary types of enteral stents include esophageal stents, gastroduodenal stents, and colon stents. Esophageal stents are specifically designed to keep the esophagus open, allowing the passage of food and liquids. They are made from various materials, including self-expandable plastic stents and self-expandable metal stents, and are used by a range of end users such as hospitals, specialty clinics, ambulatory centers, and research institutions.

The enteral stent market consists of sales of metal stents, plastic stents, covered stents, self-expanding stents, and biliary stents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.